Bengt Långström

Active 1976–2024

141
Papers
24,653
Citations
91
h-index
139
i10-index

Citations

Citations per year for Bengt Långström1961: 1 citations1978: 1 citations1984: 4 citations1985: 16 citations1986: 21 citations1987: 27 citations1988: 22 citations1989: 22 citations1990: 30 citations1991: 29 citations1992: 38 citations1993: 34 citations1994: 43 citations1995: 36 citations1996: 43 citations1997: 61 citations1998: 65 citations1999: 81 citations2000: 123 citations2001: 112 citations2002: 129 citations2003: 136 citations2004: 186 citations2005: 233 citations2006: 223 citations2007: 289 citations2008: 328 citations2009: 354 citations2010: 390 citations2011: 387 citations2012: 341 citations2013: 271 citations2014: 258 citations2015: 205 citations2016: 229 citations2017: 221 citations2018: 176 citations2019: 415 citations2020: 411 citations2021: 456 citations2022: 328 citations2023: 218 citations2024: 316 citations2025: 130 citations2026: 10 citations1962–1977: no citations, so these years are not shown1979–1983: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,767 citing papers, 29.8% of this breakdownUnited Kingdom: 854 citing papers, 9.2% of this breakdownSweden: 664 citing papers, 7.1% of this breakdownGermany: 623 citing papers, 6.7% of this breakdownCanada: 381 citing papers, 4.1% of this breakdownItaly: 379 citing papers, 4.1% of this breakdownChina: 329 citing papers, 3.5% of this breakdownNetherlands: 313 citing papers, 3.4% of this breakdownJapan: 304 citing papers, 3.3% of this breakdownFrance: 288 citing papers, 3.1% of this breakdownAustralia: 257 citing papers, 2.8% of this breakdownSpain: 220 citing papers, 2.4% of this breakdown
0%29.8%Other 20.5%

Fields

  • Medicine63.3%
  • Neuroscience19.4%
  • Biochemistry, Genetics and Molecular Biology7.8%
  • Psychology3.3%
  • Computer Science1.6%
  • Chemistry1%
  • Other3.6%

Topics

  • Alzheimer's disease research and treatments10.8%
  • Dementia and Cognitive Impairment Research7.7%
  • Functional Brain Connectivity Studies3.3%
  • Medical Imaging Techniques and Applications3.3%
  • Neuroscience and Neuropharmacology Research2.3%
  • Cholinesterase and Neurodegenerative Diseases2.1%
  • Other70.5%

Coauthors

All papers

Open in search
  1. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B

    Authors: , , , , , , , , , , , , , , , , , , , , - Annals of Neurology 2004 cited by 4,477

  2. The use of PET in Alzheimer disease

    Authors: , , , - Nature Reviews Neurology 2010 cited by 450

  3. Evidence for Astrocytosis in Prodromal Alzheimer Disease Provided by 11 C-Deuterium-L-Deprenyl: A Multitracer PET Paradigm Combining 11 C-Pittsburgh Compound B and 18 F-FDG

    Authors: , , , , , , - Journal of Nuclear Medicine 2012 cited by 435

  4. Species Differences in Blood-Brain Barrier Transport of Three Positron Emission Tomography Radioligands with Emphasis on P-Glycoprotein Transport

    Authors: , , , , , , , - Drug Metabolism and Disposition 2008 cited by 365

  5. Diverging longitudinal changes in astrocytosis and amyloid PET in autosomal dominant Alzheimer’s disease

    Authors: , , , , , , , , , , , - Brain 2016 cited by 306

  6. Low PiB PET retention in presence of pathologic CSF biomarkers in Arctic APP mutation carriers

    Authors: , , , , , , , , - Neurology 2012 cited by 174

  7. Proton pump inhibitors act with unprecedented potencies as inhibitors of the acetylcholine biosynthesizing enzyme—A plausible missing link for their association with incidence of dementia

    Authors: , , , , - Alzheimer s & Dementia 2020 cited by 68

  8. In Vivo Visualization of Amyloid Deposits in the Heart with 11C-PIB and PET

    Authors: , , , , , , , , , , , , , , - Journal of Nuclear Medicine 2012 cited by 258

  9. Early astrocytosis in autosomal dominant Alzheimer’s disease measured in vivo by multi-tracer positron emission tomography

    Authors: , , , , , , , , , - Scientific Reports 2015 cited by 146

  10. Insight into the Binding of First- and Second-Generation PET Tracers to 4R and 3R/4R Tau Protofibrils

    Authors: , , , , - ACS Chemical Neuroscience 2023 cited by 20

  11. PET imaging of amyloid deposition in patients with mild cognitive impairment

    Authors: , , , , , , , , - Neurobiology of Aging 2007 cited by 724

  12. Mapping Human Brain Monoamine Oxidase A and B with11C-Labeled Suicide Inactivators and PET

    Authors: , , , , , , , , , , , , , , , , , , - Science 1987 cited by 393

  13. Evidence for astrocytosis in ALS demonstrated by [11C](l)-deprenyl-D2 PET

    Authors: , , , , , , , - Journal of the Neurological Sciences 2007 cited by 133

  14. Positron Emission Tomography in Clinical Islet Transplantation

    Authors: , , , , , , , , , , , , - American Journal of Transplantation 2009 cited by 160

  15. Amyloid-β Positron Emission Tomography Imaging Probes: A Critical Review

    Authors: , , , , , , , , , , , , - Journal of Alzheimer s Disease 2013 cited by 83

  16. Mechanistic Insight into the Inhibition of Choline Acetyltransferase by Proton Pump Inhibitors

    Authors: , , , , , , - ACS Chemical Neuroscience 2023 cited by 27

  17. Two-year follow-up of amyloid deposition in patients with Alzheimer's disease

    Authors: , , , , , , , , , - Brain 2006 cited by 614

  18. Increased dopamine synthesis rate in medial prefrontal cortex and striatum in schizophrenia indicated by L-(β-11C) DOPA and PET

    Authors: , , , , , , - Biological Psychiatry 1999 cited by 285

  19. Comparison of Early-Phase 11C-Deuterium-l-Deprenyl and 11C-Pittsburgh Compound B PET for Assessing Brain Perfusion in Alzheimer Disease

    Authors: , , , , , , , , , - Journal of Nuclear Medicine 2016 cited by 78

  20. In vivo activity of bupropion at the human dopamine transporter as measured by positron emission tomography

    Authors: , , , , , - Biological Psychiatry 2003 cited by 175

  21. PET imaging of cortical 11C-nicotine binding correlates with the cognitive function of attention in Alzheimer’s disease

    Authors: , , , , - Psychopharmacology 2006 cited by 147

  22. PET as a tool in the clinical evaluation of pituitary adenomas.

    Authors: , , , - 1991 cited by 113

  23. Brain Networks Affected by Synchronized Sleep Visualized by Positron Emission Tomography

    Authors: , , , , , , , , , , , - Journal of Cerebral Blood Flow & Metabolism 1998 cited by 112

  24. Nerve growth factor affects11C-nicotine binding, blood flow, EEG, and verbal episodic memory in an Alzheimer patient (Case Report)

    Authors: , , , , , , , , , , , , , , , , - Journal of Neural Transmission - Parkinsons Disease and Dementia Section 1992 cited by 325